High levels of CDK1 activity have been shown to be predictive of metastasis risk in CRC since CDK1 can promote CRC progression through phosphorylation of JAK1, activating the JAK/STAT3 signaling pathway. This evidence concerns the gene CDK1 and colorectal carcinoma.